ArticleJournal of biomedical optics2026
High-performance Brillouin spectroscopy using VIPA-etalon cascades.
Article in Journal of biomedical optics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: Brillouin spectroscopy noninvasively probes mechanical properties of biological materials and has become a valuable tool in various areas of biomedical research. However, the limited contrast of conventional single stage virtually imaged phased array (VIPA) spectrometers restricts many applications. Current contrast enhancement methods have limitations, including incompatibility with line-scanning collection, which is highly advantageous for fast biomechanical mapping. Aim: The aim is to develop and characterize a high-throughput contrast enhancement technique using a VIPA-etalon cascade, designed for compatibility with both confocal and line-scanning geometries across a wide range of wavelengths. Approach: One or more etalons with approximately matched thicknesses are integrated downstream of the VIPA to suppress its Lorentzian tails. A theoretical model and ray-tracing simulation were developed, complemented by experimental validation in confocal and line-scanning setups at 785 and 532 nm, respectively. Brillouin spectra were measured for reference materials and biological samples, including a porcine crystalline lens. Results: Experimentally, the integration of a single high-finesse cascade yielded contrast enhancements of 27 and Conclusions: The VIPA-etalon cascade markedly improves the performance of Brillouin spectroscopy, offering a straightforward, cost-effective, and versatile solution for analyzing biological samples. It enables precise, high-resolution biomechanical investigations, advancing applications in biomedical research and clinical diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.